Key Takeaways
-
If breath testing for SIBO is needed, glucose breath tests are generally the preferred option because they produce fewer false positives than lactulose tests.
-
Testing can support a diagnosis, but it doesn’t always change the best place to start. Diet, probiotics, and lifestyle changes are often appropriate with or without a breath test.
-
SIBO breath test results are just one piece of the puzzle. They should always be interpreted alongside your symptoms and health history.
✓ Reviewed by our Scientific Review Board · All claims supported by peer-reviewed research · Last updated April 2026
If you’ve been told you may have small intestinal bacterial overgrowth (SIBO), one of the first questions you may ask your clinician is whether or not you should take a breath test. And if so, which one?
Two breath tests are commonly used to diagnose SIBO: the glucose breath test and the lactulose breath test. Although both can provide useful information, research consistently shows that glucose breath testing is more accurate and less likely to produce false-positive results.
Here’s what the evidence says and how to interpret SIBO breath test results.
What Is SIBO?
Small intestinal bacterial overgrowth (SIBO) is an excessive number and/or abnormal type of bacteria in the small intestine, which leads to gastrointestinal (GI) symptoms. Symptoms of SIBO include 1 2:
- Gas or flatulence
- Bloating
- Abdominal pain
- Altered bowel function, including diarrhea, constipation, or other alterations in transit time
- Weight loss or nutritional deficiencies from malabsorption
- Food intolerances, such as lactose intolerance or fructose malabsorption
Some research based on observational studies suggests SIBO may also be associated with upper gastrointestinal symptoms, including reflux or heartburn, although more research is needed to determine whether SIBO directly contributes to these symptoms 2.
SIBO has also been correlated with irritable bowel syndrome (IBS) 3 4, fibromyalgia 5, rheumatoid arthritis 6, non-responsive celiac disease 7, inflammatory bowel diseases (IBD), including Crohn’s disease 8, rosacea 9, and metabolic health issues (like being overweight) 10 11, high blood sugar 12, and high cholesterol 12. And, interestingly, one study showed that being hypothyroid was a risk factor for SIBO as well 13.
As for common causes of SIBO, the list certainly varies. This may include abdominal adhesions from injury or surgery 14, chronic constipation 14 15, use of proton pump inhibitors (PPIs) 1 16, and small intestinal diseases 17.
As we can see, it’s not a surprising contention that imbalances in the digestive system (in this case, SIBO) may correlate with many symptoms and conditions. This is why it can be very helpful to have a diagnostic test to tell you whether you have small intestinal bacterial overgrowth.
How Is SIBO Tested?
If your clinician suspects SIBO, they may recommend one of several tests. The table below summarizes the most commonly used options and what to know about each.
| Diagnostic Test | Pros | Cons |
|---|---|---|
Small bowel aspirate |
Most direct measurement |
Expensive, invasive, sampling limitations |
Glucose breath test |
Best noninvasive accuracy |
Can miss some cases |
Jejunal aspirate (small bowel aspirate culture) |
Traditionally considered the gold standard; directly measures bacterial growth in the small intestine |
Expensive, invasive, not widely available, risk of contamination, sampling limitations |
Lactulose breath test |
Widely available |
More false positives |
Three-gas (hydrogen sulfide) test |
Detects a wider range of SIBO subtypes |
Newer, less standardized interpretation |
For a breath test, you drink a glucose or lactulose solution, then collect breath samples over several hours using an at-home kit. The lab measures hydrogen and methane. In newer tests, hydrogen sulfide is tested, which is produced by bacteria in the small intestine.
How to Prepare for a SIBO Breath Test
The preparation that you do prior to testing often affects accuracy. Typical clinical guidance includes 18:
- Avoid beforehand: Antibiotics for 2 to 4 weeks, and probiotics for at least a few days, unless your provider directs otherwise.
- 24 hours before: Avoid fermentable foods, whole grains, legumes, and high-fiber vegetables that can produce gas independent of SIBO.
- 12 hours before: Fast, water only.
- Morning of: No smoking, and avoid strenuous exercise before the test, both of which can affect breath gas readings.
Skipping these steps is one of the more common and avoidable reasons for a misleading result.
Which SIBO Breath Test Is Most Accurate?
If you’re planning to run a SIBO breath test, you’ll want to opt for the highest quality one. Thankfully, a meta-analysis (a summary of all available high-quality data on a subject) has been published to give a definitive answer about which breath test is best for the diagnosis of SIBO 1 19.
Glucose vs. Lactulose SIBO Breath Testing
A 2020 systematic review and meta-analysis concluded that glucose breath tests had higher sensitivity and specificity than lactulose breath tests 19.
- Sensitivity tells you how reliably a test catches people who truly have the condition.
- Specificity tells you how reliably a test rules out people who don’t have the condition.
The study found glucose breath testing had a sensitivity of 54.5% and specificity of 83.2%, compared to 42.0% sensitivity and 70.6% specificity for lactulose breath testing 19. The lower these numbers, the higher the likelihood of a false negative or false positive.
What the Research Shows
Glucose breath testing correctly rules out SIBO in about 83% of people who don't have it, compared to roughly 71% for lactulose testing [19].
J Neurogastroenterol Motil. 2020 Jan 30; 26(1) 16-28
In practical terms, that gap matters. Lactulose is still the most widely used SIBO breath test, but its lower specificity means it flags a significantly higher number of false positives. And a false positive isn’t a neutral outcome. It’s a patient who is handed an incorrect diagnosis, put on a restrictive diet, or started on antibiotics they didn’t need.
None of this means lactulose testing is unusable. In the hands of a clinician who interprets it carefully (particularly around timing, which we cover next), it can still provide useful information. But when comparing the two tests head-to-head, the data favors glucose breath testing as a more accurate option.
Why Lactulose Breath Tests Produce More False Positives
Lactulose isn’t absorbed in the gastrointestinal tract. This means that it eventually reaches the large intestine, where bacteria will normally ferment it (regardless of SIBO) and produce hydrogen and methane. That means seeing gas increases later in the test is expected and does not automatically indicate SIBO.
Most experts treat the first 80 to 100 minutes as reflective of small intestine activity 18. Gas elevations after that window usually reflect normal colonic fermentation, not abnormal bacterial overgrowth. When those late increases (caused by the lactulose not fermenting) get read as a false-positive result, patients end up with an incorrect SIBO diagnosis and treatment they didn’t need.
This interpretation error is common enough that it’s worth naming directly: the test itself isn’t the only variable. How a clinician reads the curve determines whether the diagnosis is accurate.
Clinical Observation
Glucose breath testing has better sensitivity and specificity than lactulose testing and should be the preferred option in clinical practice.
The Ruscio Institute
The Newer Three-Gas Test
Standard breath tests measure hydrogen and methane. Some people’s SIBO cases, however, are driven by hydrogen sulfide-producing bacteria, which produce another fermentation gas that is not detected by standard two-gas breath tests. Newer “three-gas tests” (measuring hydrogen, methane, and hydrogen sulfide) are designed to catch this subtype 1 20.
Hydrogen sulfide is produced by sulfate-reducing bacteria in the gut. Emerging research suggests it may contribute to gastrointestinal symptoms such as diarrhea, abdominal pain, bloating, and urgency in some patients, particularly those with diarrhea-predominant symptoms 21. Because hydrogen sulfide can consume hydrogen during its production, some people with hydrogen sulfide overgrowth may have normal hydrogen levels on a standard breath test despite ongoing symptoms 1 18 20.
Because the newer three-gas breath tests measure hydrogen, methane, and hydrogen sulfide, it makes it possible to identify this previously undetectable pattern.
Early studies suggest these tests may improve diagnostic yield in some patients, but clinical interpretation is still evolving. Normal ranges, diagnostic thresholds, and the best way to use hydrogen sulfide results in clinical practice continue to be refined, and current guidelines have not yet established three-gas testing as the standard first-line approach for all patients 1 22 23.
The evidence base here is in the earlier stages compared to the glucose vs. lactulose research, and interpretation standards are still being refined. For now, a three-gas test is worth discussing with your provider if symptoms persist despite a negative standard test, rather than as a first-line option for everyone.
How Helpful Is SIBO Testing?
Breath testing is useful, but it’s not the final word. The authors of a meta-analysis note that although breath tests underperform compared with the gold-standard test (culture of jejunal aspirate), they’re still valuable because they’re far less expensive and invasive than a small bowel aspirate 19.
Testing helps narrow the picture, but plenty of effective SIBO therapies don’t require a positive result first. Probiotics are a good example: Multiple clinical trials and a meta-analysis support their use for SIBO and related microbiome imbalances 24 25. The same support likely holds for small intestinal fungal overgrowth (SIFO), given the antifungal effects of certain probiotic strains.
When SIBO breath testing is worth doing:
- You’ve already tried diet, probiotics, and lifestyle changes without meaningful improvement
- Your provider needs more information before prescribing a specific treatment
- You aren’t scheduled for an endoscopy any time soon, but you still want to screen yourself for SIBO with a breath test
- Symptoms are severe, atypical, or suggest a different digestive condition entirely
SIBO Breath Test FAQs
At-home kits typically run $150 to $250 out of pocket, and insurance coverage varies widely depending on whether it’s billed as a diagnostic test tied to a specific condition. Some functional medicine clinics include testing as part of a broader workup, which can shift the cost calculation. Given that testing doesn’t always change your first treatment step, it’s worth weighing that cost compared to the benefits of starting with diet, probiotics, and lifestyle changes first.
Yes. Both glucose and lactulose breath tests can produce false-positive and false-negative results. Lactulose testing is especially prone to false positives when gas increases occur after the solution has reached the large intestine, where fermentation is normal. This is why test interpretation is just as important as the test itself.
Not necessarily. While breath testing can provide useful information in some cases, it doesn’t always change the initial treatment plan. Many people improve with evidence-based therapies such as dietary changes, probiotics, and lifestyle modifications without undergoing testing. We generally reserve testing for people who haven’t responded to these first-line approaches or when the results are likely to change treatment decisions.
A positive breath test is just one piece of the puzzle. It doesn’t automatically mean you need antibiotics or a highly restrictive diet. Your healthcare provider should interpret your results alongside your symptoms, medical history, and other clinical findings. Depending on your situation, treatment may include dietary changes, probiotics, herbal therapies, prescription medications, or a combination of approaches.
Current research suggests the glucose breath test is more accurate than the lactulose breath test. A large systematic review and meta-analysis found that glucose testing has higher sensitivity and specificity and is less likely to produce false-positive results, particularly those caused by normal fermentation in the large intestine 19.
Yes. In many cases, it is reasonable to begin evidence-based therapies without a breath test, particularly when symptoms are consistent with SIBO or other gut microbiome imbalances. Because first-line treatments such as dietary modifications, probiotics, and lifestyle changes are often appropriate regardless of breath test results, testing is not always necessary before getting started.
SIBO Breath Testing: Bottom Line
Breath testing can be useful, but it isn’t always necessary. For patients who do pursue testing, current evidence favors the glucose breath test because it produces fewer false positives than the lactulose breath test. At the same time, no breath test is currently considered perfect, which is why we rarely base treatment decisions on test results alone. Our approach at the clinic is to use testing selectively and prioritize safe, evidence-based therapies that help patients feel better regardless of what a breath test shows.
Liked this article? Get weekly gut health insights.
Join 40,000+ readers who get evidence-based health tips — no spam, no fluff.
By subscribing you agree to our Privacy Policy. Unsubscribe anytime.
One of the biggest mistakes we see is people spending time and money on testing that doesn’t meaningfully change their treatment plan. Our clinicians can help you determine whether testing is appropriate or if it’s better to start with proven therapies that can begin improving symptoms right away.
Book a virtual consultation with our team to get a personalized, step-by-step treatment plan.
Continue Reading
➕ References
- Pimentel M, Saad RJ, Long MD, Rao SSC. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020 Feb;115(2):165–78. DOI: 10.14309/ajg.0000000000000501. PMID: 32023228.
- Quigley EMM, Murray JA, Pimentel M. AGA clinical practice update on small intestinal bacterial overgrowth: expert review. Gastroenterology. 2020 Oct;159(4):1526–32. DOI: 10.1053/j.gastro.2020.06.090. PMID: 32679220.
- Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, et al. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014 Jun;79(2):96–134. DOI: 10.1016/j.rgmx.2014.01.004. PMID: 24857420.
- Takakura W, Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update. Front Psychiatry. 2020 Jul 10;11:664. DOI: 10.3389/fpsyt.2020.00664. PMID: 32754068. PMCID: PMC7366247.
- Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004 Apr;63(4):450–2. DOI: 10.1136/ard.2003.011502. PMID: 15020342. PMCID: PMC1754959.
- Podas T, Nightingale JMD, Oldham R, Roy S, Sheehan NJ, Mayberry JF. Is rheumatoid arthritis a disease that starts in the intestine? A pilot study comparing an elemental diet with oral prednisolone. Postgrad Med J. 2007 Feb;83(976):128–31. DOI: 10.1136/pgmj.2006.050245. PMID: 17308218. PMCID: PMC2805936.
- Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003 Apr;98(4):839–43. DOI: 10.1111/j.1572-0241.2003.07379.x. PMID: 12738465.
- Shah A, Morrison M, Burger D, Martin N, Rich J, Jones M, et al. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther. 2019 Mar;49(6):624–35. DOI: 10.1111/apt.15133. PMID: 30735254.
- Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008 Jul;6(7):759–64. DOI: 10.1016/j.cgh.2008.02.054. PMID: 18456568.
- Mathur R, Amichai M, Chua KS, Mirocha J, Barlow GM, Pimentel M. Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. J Clin Endocrinol Metab. 2013 Apr;98(4):E698-702. DOI: 10.1210/jc.2012-3144. PMID: 23533244. PMCID: PMC3615195.
- Basseri RJ, Basseri B, Pimentel M, Chong K, Youdim A, Low K, et al. Intestinal methane production in obese individuals is associated with a higher body mass index. Gastroenterol Hepatol (N Y). 2012 Jan;8(1):22–8. PMID: 22347829. PMCID: PMC3277195.
- Mathur R, Chua KS, Mamelak M, Morales W, Barlow GM, Thomas R, et al. Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity. Obesity (Silver Spring). 2016 Mar;24(3):576–82. DOI: 10.1002/oby.21385. PMID: 26833719. PMCID: PMC4769647.
- Patil AD. Link between hypothyroidism and small intestinal bacterial overgrowth. Indian J Endocrinol Metab. 2014 May;18(3):307–9. DOI: 10.4103/2230-8210.131155. PMID: 24944923. PMCID: PMC4056127.
- Brechmann T, Sperlbaum A, Schmiegel W. Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: Results of a retrospective cohort study. World J Gastroenterol. 2017 Feb 7;23(5):842–52. DOI: 10.3748/wjg.v23.i5.842. PMID: 28223728. PMCID: PMC5296200.
- Roland BC, Ciarleglio MM, Clarke JO, Semler JR, Tomakin E, Mullin GE, et al. Small intestinal transit time is delayed in small intestinal bacterial overgrowth. J Clin Gastroenterol. 2015 Aug;49(7):571–6. DOI: 10.1097/MCG.0000000000000257. PMID: 25319735.
- Su T, Lai S, Lee A, He X, Chen S. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. J Gastroenterol. 2018 Jan;53(1):27–36. DOI: 10.1007/s00535-017-1371-9. PMID: 28770351.
- Losurdo G, Marra A, Shahini E, Girardi B, Giorgio F, Amoruso A, et al. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis. Neurogastroenterol Motil. 2017 Jun;29(6). DOI: 10.1111/nmo.13028. PMID: 28191721.
- Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017 May;112(5):775–84. DOI: 10.1038/ajg.2017.46. PMID: 28323273. PMCID: PMC5418558.
- Losurdo G, Leandro G, Ierardi E, Perri F, Barone M, Principi M, et al. Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis. J Neurogastroenterol Motil. 2020 Jan 30;26(1):16–28. DOI: 10.5056/jnm19113. PMID: 31743632. PMCID: PMC6955189.
- Villanueva-Millan MJ, Leite G, Mathur R, Rezaie A, Fajardo CM, de Freitas Germano J, et al. Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens. Dig Dis Sci. 2025 Nov;70(11):3846–56. DOI: 10.1007/s10620-025-09156-y. PMID: 40569514.
- Villanueva-Millan MJ, Leite G, Wang J, Morales W, Parodi G, Pimentel ML, et al. Methanogens and hydrogen sulfide producing bacteria guide distinct gut microbe profiles and irritable bowel syndrome subtypes. Am J Gastroenterol. 2022 Dec 1;117(12):2055–66. DOI: 10.14309/ajg.0000000000001997. PMID: 36114762. PMCID: PMC9722381.
- Wallace JL, Motta J-P, Buret AG. Hydrogen sulfide: an agent of stability at the microbiome-mucosa interface. Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G143–9. DOI: 10.1152/ajpgi.00249.2017. PMID: 29025733. PMCID: PMC5866422.
- Singh SB, Lin HC. Hydrogen sulfide in physiology and diseases of the digestive tract. Microorganisms. 2015 Nov 12;3(4):866–89. DOI: 10.3390/microorganisms3040866. PMID: 27682122. PMCID: PMC5023273.
- Martyniak A, Wójcicka M, Rogatko I, Piskorz T, Tomasik PJ. A comprehensive review of the usefulness of prebiotics, probiotics, and postbiotics in the diagnosis and treatment of small intestine bacterial overgrowth. Microorganisms. 2025 Jan 1;13(1). DOI: 10.3390/microorganisms13010057. PMID: 39858825. PMCID: PMC11768010.
- Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. J Clin Gastroenterol. 2017 Apr;51(4):300–11. DOI: 10.1097/MCG.0000000000000814. PMID: 28267052.